Sunesis Pharmaceuticals Provides Corporate Update
July 07, 2020 16:01 ET
|
Sunesis Pharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif., July 07, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced a reduction in workforce of approximately 30% of its head count to focus...
Sunesis Pharmaceuticals Announces Clinical Update on Vecabrutinib Program
June 23, 2020 07:30 ET
|
Sunesis Pharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif., June 23, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that the Company will not advance its non-covalent BTK inhibitor...
Sunesis Pharmaceuticals Reports First Quarter 2020 Financial Results and Recent Highlights
May 07, 2020 16:05 ET
|
Sunesis Pharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the first quarter ended March 31, 2020. Loss from...
Sunesis Pharmaceuticals to Host Conference Call on May 7th to Discuss First Quarter 2020 Financial Results and Recent Highlights
April 30, 2020 07:00 ET
|
Sunesis Pharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Thursday, May 7th, 2020 at 4:30...
Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results and Recent Highlights
March 10, 2020 16:05 ET
|
Sunesis Pharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif., March 10, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the fourth quarter and year ended December 31, 2019....
Sunesis Pharmaceuticals to Host Conference Call on March 10th to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Recent Highlights
March 03, 2020 07:00 ET
|
Sunesis Pharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif., March 03, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Tuesday, March 10, 2020 at 4:30...
Sunesis Pharmaceuticals to Present at the 40th Annual Cowen Health Care Conference
February 25, 2020 16:05 ET
|
Sunesis Pharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Willie Quinn, Chief Financial Officer and Senior Vice President,...
Sunesis Pharmaceuticals Announces Data from Ongoing Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies
December 05, 2019 11:41 ET
|
Sunesis Pharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced data from the Company’s Phase 1b/2 clinical trial of its non-covalent BTK...
Sunesis Pharmaceuticals Reports Third Quarter 2019 Financial Results and Recent Highlights
November 12, 2019 16:05 ET
|
Sunesis Pharmaceuticals, Inc.
Phase 1b/2 Trial of Vecabrutinib in 400 mg Cohort; Clinical Update at Upcoming ASH Annual Meeting Sunesis to Host Conference Call Today at 4:30 PM Eastern Time SOUTH SAN FRANCISCO, Calif., Nov. ...
Sunesis Pharmaceuticals to Present at 28th Annual Credit Suisse Healthcare Conference
November 08, 2019 07:00 ET
|
Sunesis Pharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 08, 2019 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Willie Quinn, Chief Financial Officer and Senior Vice President,...